Headlines National

Serum Institute ke approval mangishe

Agencies, 12 September: Drug Controller General of India (DCGI) para India te Coronavirus nemide trial suru koribo karni  Serum Institute of India (SII) para approval toh Data Safety Monitoring Boards (DSMB) of India aro UK para pabole koise.

Apex drug controller body para SII ke tai khan  para  approvals toh vaccine laga trial nemide volunteers ke aro recruitment nakora agae te debole adesh deshe.  Etu approval napowa tai trials nemide recruitment toh suspend te thakibole koise.

DCGI para etu direction toh Friday te deya ase kelay koile agae din Drug Controller General of India laga office para ekta show-cause notice bechide SII official para India te jai thaka trials rokhaideya bechide ase.

Pune-based vaccine manufacturer para tai khan Covishield vaccine laga trials toh AstraZeneca para suru nakora tak India te rokhai ase kowa thakise.